HOBSCOTCH-MS: Home-based telehealth cognitive coaching for people with multiple sclerosis
Official title: HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS) - Efficacy Trial
Run by Dartmouth-Hitchcock Medical Center · NCT06951919 · Data updated 2026-11-12
This program will test whether a home-based telehealth cognitive coaching program (HOBSCOTCH-MS) can improve thinking, memory, and quality of life for people with MS and reduce caregiver burden.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 75 Years |
| Sex | All |
| Enrollment | 125 (estimated) |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 1 site (Lebanon, New Hampshire) |
| Status | Recruiting |
| Started | September 9, 2025 |
| Main results expected | May 2028 |
| Study ends | December 2028 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT06951919 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20–75 with relapsing or progressive MS who report cognitive or memory problems, have at least a high school education, are fluent in English, and have reliable internet and telephone access are the intended participants.
✕Probably not a fit
People with active severe psychiatric disorders, other neurological illnesses that affect cognition, diagnosed developmental or intellectual disorders, or without internet/telephone access or English fluency are unlikely to be eligible or to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
HOBSCOTCH-MS delivers one-on-one virtual sessions with a certified cognitive coach, starting with a preparatory session followed by eight weekly 45–60 minute sessions focused on self-management, memory strategies, and cognitive training. People with MS are randomized to begin the program immediately or after a three-month waitlist, and optional caregivers may enroll alongside the person with MS. Participants are followed for about six months and will complete measures of quality of life, subjective and objective cognition, problem-solving, self-efficacy, and mood, with caregiver burden and knowledge also tracked. The study will examine which baseline factors predict benefit and whether changes in problem-solving and self-efficacy mediate cognitive and quality-of-life outcomes.
Why it matters
Potential benefit: If effective, HOBSCOTCH-MS could improve everyday thinking and memory, raise quality of life for people with MS, and reduce caregiver stress.
How similar studies have gone: Previous HOBSCOTCH programs and other telehealth cognitive rehabilitation trials have shown promising improvements in subjective cognition and quality of life in small studies, but large randomized MS-specific evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion Criteria - MS Participant * Age 20 - 75 years * Diagnosis of relapsing or progressive MS * Education of at least Grade 12 or GED * Fluent in English * Subjective cognitive and memory challenges * Internet access * Telephone access Inclusion Criteria - Caregiver Participant * 20 years + * Fluent in English * Caregiver to a MS Participant * Participant MS has given permission to Caregiver to enroll with them * Internet access * Telephone access Exclusion Criteria: * Exclusion Criteria MS Participant * Current diagnosed psychiatric disorders (e.g., schizophrenia, bipolar disorder or substance use disorder). * Other neurological disorder such as epilepsy, brain tumor, severe brain injury or mild to moderate brain injury with a history of 30 or more minutes' loss of consciousness, or other disorder that would confound the focus on MS * Diagnosed developmental attention, learning, or intellectual disorder; sensory, motor, or physical disability that would prevent engagement with the intervention or render the person unable complete study outcome measures * Exacerbation of MS symptoms (relapse) or ongoing steroid treatment within three months of study enrollment * Significant visual impairment precluding reading or writing * Lack of access to the technical resources (e.g., internet access, telephone) required for participation Exclusion Criteria - Caregiver Participant * Significant visual impairment precluding reading or writing * No reliable telephone or internet access
Where it's running
-
Dartmouth-Health Lebanon
Lebanon, New Hampshire, United States Recruiting
Study contacts
- Principal investigator: Elaine T Kiriakopoulos — Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College
- Study coordinator: Meredith E Olenec
- Email: HOBSCOTCH-MS.Research@Hitchcock.org
- Phone: 603-650-4225
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-based self-management and cognitive training for brain tumor survivors
This trial will try a home-based cognitive coaching program to see if it improves thinking and quality of life for adults who survived non-glioblastoma brain tumors, with optional caregiver participation.
-
Spatial scene memory testing for people with temporal lobe epilepsy having surgery
This project tests whether a virtual tour memory task combined with brain recordings can show how adults with temporal lobe epilepsy recognize and recall places.
-
Eye scan to detect Alzheimer’s related protein deposits in adults with memory issues
A screening eye test is being tried in adults with memory problems to see if retinal changes can signal Alzheimer’s-related protein deposits.
-
Sexual problems in women with relapsing-remitting multiple sclerosis
See if sexual dysfunction is common in women aged 25-50 with relapsing-remitting MS and whether it's linked to fatigue, mood, bladder symptoms, and cognitive problems.
-
Nutrition-based interventions to prevent cognitive decline
This study is testing if a 6-month nutrition program can help adults at higher risk for dementia keep their thinking skills sharp.
-
Investigating biomarkers related to Alzheimer's disease and cognitive impairment
This study is trying to see how blood tests and brain scans relate to Alzheimer's disease and memory issues in older adults aged 60 to 90.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.